Camp4 Therapeutics (CAMP) Operating Expenses (2023 - 2026)
Camp4 Therapeutics (CAMP) posted Operating Expenses of $14.4 million for Q1 2026, up 9.46% sequentially from $13.1 million in Q4 2025, and up 2.92% YoY from $14.0 million in Q1 2025.
Camp4 Therapeutics (CAMP) Operating Expenses (2023 - 2026) Analysis & Trends
Camp4 Therapeutics has reported Operating Expenses for 4 years, with the latest figure at $14.4 million in Q1 2026.
- Quarterly Operating Expenses rose 2.92% year-over-year to $14.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $56.5 million (up 2.99% YoY) and the FY2025 annual result came in at $56.1 million, up 4.3% from the prior year.
- Operating Expenses improved to $14.4 million in Q1 2026 per CAMP's latest filing, from $13.1 million in the prior quarter.
- Over five years, Operating Expenses peaked at $14.7 million in Q4 2024 and troughed at $12.7 million in Q2 2024.
- A 4-year average of $13.7 million and a median of $13.5 million in 2024 frame the typical range for Operating Expenses.
- The widest YoY moves for Operating Expenses: up 14.71% in 2025, down 10.64% in 2025.
- Over 4 years, Operating Expenses stood at $13.5 million in 2023, then climbed by 8.98% to $14.7 million in 2024, then decreased by 10.64% to $13.1 million in 2025, then grew by 9.46% to $14.4 million in 2026.
- According to Business Quant data, Operating Expenses over the past three periods registered $14.4 million, $13.1 million, and $14.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.09 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 3.00 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 2.89 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 505.13 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.21 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 4,978.15 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 541.02 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.06 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 427.03 Mn |
| 10 | Camp4 Therapeutics | 282.48 Mn | 282.48 Mn | - | 15.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 15.16 Mn |
| Mar 31, 2026 | 14.37 Mn |
| Dec 31, 2025 | 13.12 Mn |
| Sep 30, 2025 | 14.45 Mn |
| Jun 30, 2025 | 14.53 Mn |
| Mar 31, 2025 | 13.96 Mn |
| Dec 31, 2024 | 14.69 Mn |
| Sep 30, 2024 | 13.52 Mn |
| Jun 30, 2024 | 12.66 Mn |
| Mar 31, 2024 | 12.88 Mn |
| Dec 31, 2023 | 13.48 Mn |
| Sep 30, 2023 | 12.69 Mn |